Evaluation of Graft Material in Coronary Artery Bypass Grafting (CABG)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01310725|
Recruitment Status : Completed
First Posted : March 8, 2011
Last Update Posted : March 8, 2011
The aim of the study is to evaluate the patency in different kinds of vessels used as graft material in coronary artery bypass grafting.
The hypothesis is that vein grafts harvested with a pedicle of surrounding tissue have the same, or better, patency compared to radial grafts and that skeletonisation of the left internal mammary artery does not effect the patency for this graft.
|Condition or disease||Intervention/treatment||Phase|
|Angina Pectoris||Procedure: Coronary artery bypass grafting||Not Applicable|
Patients undergoing coronary artery bypass grafting are included in the study.
Each patient receive a radial artery graft and a vein graft harvested with a pedicle of surrounding tissue to the right and left side of the heart respectively. The left internal mammary artery is used for the left anterior descending artery in a skeletonised or non-skeletonised fashion.
The evaluation is made with angiography up to 5 years after surgery.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||108 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Mid-term Patency of Radial Artery and No Touch Saphenous Vein as Grafts in CABG; A Randomised Controlled Trial.|
|Study Start Date :||January 2004|
|Actual Primary Completion Date :||November 2010|
|Actual Study Completion Date :||November 2010|
Procedure: Coronary artery bypass grafting
- Functional grafts defined as opened or closed. [ Time Frame: Up to 5 years after surgery. ]
- Degree of stenosis in implanted grafts. [ Time Frame: Up to 5 years after surgery. ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01310725
|Dept of Cardiothoracic Surgery, Orebro University Hospital|
|Orebro, Sweden, 701 85|
|Study Chair:||Lars Norgren, MD, PhD, Prof.||Orebro University|